Coronavirus

Bit by bit we are getting back to normal. Over half of the American adult population is now vaccinated, and vaccines will soon be available in most locations on a walk-in basis. At current rates, [...]

On March 2 the Biden administration announced a vaccine manufacturing partnership between two of the largest and most successful drug manufacturers in the United States: Johnson & Johnson and [...]

The United States approved a third COVID-19 vaccine—the latest from Johnson and Johnson—for use, offering up millions of more doses for Americans. As I stated in my video yesterday, vaccines [...]

Here’s some good news for a change: the US has approved its third vaccine option–Johnson and Johnson’s single-dose shot–even as total daily vaccinations with the two-shot [...]

Much of current media coverage of the corona virus is focusing on the issue of variants of SARS-COV-2, the virus that causes COVID-19. Here in the United States, we’re currently in a race against [...]

Let’s begin with the bad news. The United States has not seen any meaningful expansion of coronavirus testing since the November 2020 fall-off (see the stall in the purple graph below). [...]

COVID-19’s Thanksgiving surge is upon us. We’re now facing record cases, hospitalizations and deaths and will continue at least through the end of January 2021. But [...]

It is a rare bit of good news we have to share in general, and especially in 2020, so we’re taking it! Less than a year after the broader world found out about an emerging new coronavirus [...]

In my latest dispatch, I discuss the resources I look at when analyzing the current snapshots of where we are in the corona pandemic, as well as where I think we’re headed this Fall and [...]

The previous two dispatches touched on the best-case scenario and the “not good” scenario, and why both indicate the public health response and the economic [...]